Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 339-345

  Bell, Jan M ^a   Turnidge, John D ^a   Ballow, Charles H ^b   Jones, Ronald N ^c,d   Turnidge, J ^a   Benn, R ^e   Grayson, L ^f   Faoagali, J ^g   Christiansen, K ^h   Cheng, A ⁱ   Tsang, D ^j   Kohno, S ^k   Yamaguchi, K ^l   Kahu, M ^m   Woo, J H ⁿ   Choi, K W ^o   Lee, K W ^p   Yeo, M ^q   Kumarasinghe, G ^u   Hsueh, Po Ren ^r   Liu, Y C ^s   Leu, H S ^t   more..

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b Buffalo Clinical Research Center   (United States)

^c JMI LABORATORIES   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h ROYAL PERTH HOSPITAL   (Australia)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^k NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l TOHO UNIVERSITY   (Japan)

^m TOHOKU UNIVERSITY   (Japan)

ⁿ University of Ulsan   (South Korea)

^o Seoul National University Hospital   (South Korea)

^p Yonsei University   (South Korea)

^q SINGAPORE GENERAL HOSPITAL   (Singapore)

^r NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^s KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^t CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^u Chang Gung Memorial Hospital ^*

more..

Author keywords

Linezolid; Western Pacific region; ZAPS

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; LINEZOLID; OXACILLIN; PENICILLIN G; TEICOPLANIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIFFUSION; DILUTION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PACIFIC ISLANDS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; WESTERN HEMISPHERE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; AUSTRALIA; DATA COLLECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FAR EAST; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STREPTOCOCCUS PNEUMONIAE;

EID: 0037326467     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg074     Document Type: Article

References (21)

1. Bell, J. M., Turnidge, J. D. & the SENTRY APAC participants. (2002). High prevalence of oxacillin-resistant Staphylococcus aureus from hospitalised patients in the Asia-Pacific and South Africa: results from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrobial Agents and Chemotherapy 46, 879-81.
2. Song, J. H., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W. et al. (1999). Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clinical Infectious Diseases 28, 1206-11.
3. Turnidge, J. D., Bell, J. M. & Collignon, P. J. (1999). Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study Group. Medical Journal of Australia 170, 152-5.
4. Bell, J., Turnidge, J., Coombs, G. & O'Brien, F. (1998). Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Communicable Diseases Intelligence 22, 249-52.
5. Hiramatsu, K., Hanaki, H., Ino, T., Yabatu, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy 40, 135-6.
6. Swaney, S. M., Aoki, H., Ganoza, M. C. & Shinabarger, D. L. (1998). The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrobial Agents and Chemotherapy 42, 3251-5.
7. Jones, R. N., Johnson, D. M. & Erwin, M. E. (1996). In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrobial Agents and Chemotherapy 40, 720-6.
8. Rybak, M. J., Cappelletty, D. M., Moldovan, T., Aeschlimann, J. R. & Kaatz, G. W. (1998). Comparative in vitro activities and post-antibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium. Antimicrobial Agents and Chemotherapy 42, 721-4.
9. Diekema, D. J. & Jones, R. N. (2001). Oxazolidinone antibiotics. Lancet 358, 1975-82.
10. Jones, R. N., Ballow, C. H. & Biedenbach, D. H. (2001). Multi-laboratory assessment of the linezolid spectrum using the KirbyBauer disk diffusion method. Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States. Diagnostic Microbiology and Infectious Disease 40, 59-66.
11. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
12. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A7. NCCLS, Wayne, PA, USA.
13. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing-Twelfth Informational Supplement: M100-S12. NCCLS, Wayne, PA, USA.
14. Brakstad, O. G., Maeland, J. A. & Tveten, Y. (1993). Multiplex polymerase chain reaction for detecting the genes for Staphylococcus aureus thermonuclease and methicillin resistance and correlation with oxacillin resistance. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 101, 681-8.
15. Bell, J. M., Paton, J. C. & Turnidge, J. (1998). Emergence of vancomycin-resistant enterococci in Australia: phenotypic characteristics of isolates. Journal of Clinical Microbiology 36, 2187-90.
16. Fines, M. & LeClercq, R. (2000). Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. Journal of Antimicrobial Chemotherapy 45, 797-802.
17. Ballow, C. H., Jones, R. N. & Biedenbach, D. J. (2002). A multicenter evaluation of linezolid antimicrobial activity in North America. Diagnostic Microbiology and Infectious Disease 43, 75-83.
18. Ballow, C. H., Biedenbach, D. J., Rossi, F. & Jones, R. N. (2002). Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® antimicrobial potency study in Latin America (LA-ZAPS). Brazilian Journal of Infectious Disease 6, 100-9.
19. Gemmell, C. G. (2001). Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison. Journal of Antimicrobial Chemotherapy 48, 47-52.
20. Henwood, C. J., Livermore, D. M., Johnson, A. P., James, D., Warner, M., Gardiner, A. et al. (2000). Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. Journal of Antimicrobial Chemotherapy 46, 931-40.
21. Bolmstrom, A., Ballow, C. H., Qwarnstrom, A., Biedenbach, D. J. & Jones, R. N. (2002). Multicenter assessment of linezolid antimicrobial activity and spectrum in Europe. Clinical Microbiology and Infection, in press.